Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Richard Ferrari
AddedMar 31, 2024
UpdatedMay 31, 2026
Richard Ferrari

Richard Ferrari

Founder, Saratoga Ventures

Crunchbase

Richard Ferrari's Career

Saratoga Ventures
Saratoga Ventures

Mountain View, CA, US

Founder
Tenon Medical
Tenon Medical

Los Gatos, CA, US

Board Member· Board
Pulmonx
Pulmonx

Redwood City, CA, US

Board Member· Board
Hawthorne Effect
Hawthorne Effect

Lafayette, CA, US

Board Member· Board
Spiracur
Spiracur

Sunnyvale, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Richard Ferrari's Career

Saratoga Ventures
Saratoga Ventures
Investment FirmInvestment Firm62016Mountain View, CA, US
Founder

Similar to Saratoga Ventures

Sante VenturesSante VenturesAustin, TX, USest. 2006Sante VenturesAustin, TX, US · est. 2006

Sante Ventures: A US-based venture capital firm investing in life sciences, medical tech, and healthcare.

Investment Firm74
Saratoga InvestmentSaratoga InvestmentNew York City, NY, USest. 2007Saratoga InvestmentNew York City, NY, US · est. 2007

Saratoga Investment Corp: A NYSE-traded, middle-market investment firm specializing in leveraged loans and mezzanine debt.

Investment Firm · $52.5M29
Catalysta VenturesCatalysta VenturesDurham, NC, USest. 2010Catalysta VenturesDurham, NC, US · est. 2010

Hatteras Venture Partners: A US-based venture capital firm investing in healthcare and biopharmaceutical sectors.

Investment Firm8
Bioventures InvestorsBioventures InvestorsWellesley, MA, USest. 1998Bioventures InvestorsWellesley, MA, US · est. 1998

BioVentures Investors, LLC: A US-based venture capital firm specializing in life sciences and healthcare sectors.

Investment Firm12
Tenon Medical
Tenon Medical
Acquired$12.8M02012Los Gatos, CA, US
Board Member· Board

Leadership at Tenon Medical

Robert WeigleRobert WeigleBoard Member
Steven M. FosterSteven M. FosterCEO
Pulmonx
Pulmonx
Public$276.9M2691998Redwood City, CA, US
Board Member· Board

Leadership at Pulmonx

Glendon E. FrenchGlendon E. FrenchBoard Member
Rodney PerkinsRodney PerkinsBoard Member
Daniel P FlorinDaniel P FlorinBoard Member
Michael MatlyMichael MatlyBoard Member
Staffan LindstrandStaffan LindstrandBoard Member
Dana G. MeadDana G. MeadBoard Member

Similar to Pulmonx

PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
InogenInogenGoleta, CA, USHealthcare, Medical Devicesest. 2001InogenGoleta, CA, US · est. 2001

Inogen, Inc.: Global developer and manufacturer of healthcare products for pulmonary disease patients.

Public · $73.3M1k
Pneuma RespiratoryPneuma RespiratoryBoone, NC, USMedical Equipmentest. 2015Pneuma RespiratoryBoone, NC, US · est. 2015

Pneuma Respiratory, Inc.: A US-based medical equipment manufacturer specializing in digital lung therapies.

Public · $23.3M5
RespirixRespirixSan Francisco, CA, USHealth Software, Medical Devicesest. 2015RespirixSan Francisco, CA, US · est. 2015

Digital health innovator offering non-invasive pulmonary insights for home and critical care.

Seed · $2.8M5
Hawthorne Effect
Hawthorne Effect
Acquired$23.1M02015Lafayette, CA, US
Board Member· Board

Leadership at Hawthorne Effect

Sharon KedarSharon KedarBoard Member
Jodi AkinJodi AkinBoard Member
Ilya KirnosIlya KirnosBoard Member

Similar to Hawthorne Effect

ClinOneClinOneNeedham, MA, USClinical Trialsest. 2016ClinOneNeedham, MA, US · est. 2016

ClinOne: Streamlining clinical trials with web and mobile solutions for improved patient experience.

Series A · $10.5M75
Endpoint ClinicalEndpoint ClinicalSan Francisco, CA, USClinical Trial Softwareest. 2009Endpoint ClinicalSan Francisco, CA, US · est. 2009

Study software provider, Endpoint, designs and tests interactive data access platforms via phones.

Seed · $1.7M606
SubjectWellSubjectWellAustin, TX, USPatient Recruitmentest. 2012SubjectWellAustin, TX, US · est. 2012

SubjectWell: A risk-free marketplace for efficient patient recruitment in clinical trials.

Series B · $46.8M185
Clinical.LyClinical.LyNew York City, NY, USClinical Research, Softwareest. 2019Clinical.LyNew York City, NY, US · est. 2019

Clinical.ly: Streamlining clinical research with intuitive, tailored tech solutions.

Pre-Seed · $1.1M30
Spiracur
Spiracur
Public$75.5M752007Sunnyvale, CA, US
Board Member· Board

Leadership at Spiracur

Chris FashekChris FashekBoard Member
Eric KimEric KimBoard Member
Moshe PintoMoshe PintoBoard Member
Gary RestaniGary RestaniBoard Member

Richard Ferrari's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Richard Ferrari

Richard DeslauriersRichard DeslauriersFounder · InventureReza AzarderakhshReza AzarderakhshFounder · PqsecureRichard HendriksRichard HendriksCo-Founder · Pied PiperIvan SydorenkoIvan SydorenkoFounder · pvqPaul TaylorPaul TaylorCo-Founder · QponQrushDavid BellDavid BellBoard Member · Pegasus Capital